Thrombogenics Aktie

Watchlist TG4 WKN A0J30B ISIN BE0003846632
- -
-

Was macht Thrombogenics?

Unternehmensprofil
Unternehmensprofil

Oxurion NV is a biopharmaceutical company, which engages in developing and commercializing medicines for the treatment of vitreo retinal diseases. It operates under JETREA brand name. The company was founded by Desire Collen in 1991 and is headquartered in Leuven, Belgium.

Chart der Thrombogenics Aktie

Charttool öffnen